{"longTitle":"Gene Expression (van de Vijver et al. NEJM 2002) ","cohort":"Breast Cancer (Vijver 2002)","url":"http://www.ncbi.nlm.nih.gov/pubmed/12490681","probeMap":"probeAgilentVV","dataSubType":"gene expression","citation":"N Engl J Med. 2002 Dec 19;347(25):1999-2009","label":"gene expression","articletitle":"A gene-expression signature as a predictor of survival in breast cancer.","tags":["cancer"],"anatomical_origin":["Breast"],"name":"vijver2002_public/vijver2002_genomicMatrix","dataproducer":"van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R","wrangling_procedure":"Expression and clinical data were downloaded from Rosetta Inpharmatics. Expression data provided by Rosetta Inpharmatics was stored as log-ratio, so no further normalization was performed. Oligos from platform were mapped with 100% identity to hg18 to find chromosomal location of probes. Expression data was converted to bed15 format using these probe annotations.","sample_type":["tumor"],"type":"genomicMatrix","wrangler":"Zack Sanborn","version":"2011-11-01","gdata_tags":["transcription","mRNA"],"shortTitle":"van de Vijver Gene Exp","primary_disease":"breast cancer"}

Gene Expression (van de Vijver et al. NEJM 2002)

{"cohort":"Breast Cancer (Vijver 2002)","url":"http://www.ncbi.nlm.nih.gov/pubmed/12490681","dataSubType":"phenotype","label":"Phenotypes","tags":["cancer","survival"],"name":"vijver2002_public/vijver2002_public_clinicalMatrix","clinicalfeature":"vijver2002_public/vijver2002_public_clinicalFeature","type":"clinicalMatrix","wrangler":"Zack Sanborn","version":"2011-11-11"}

{"cohort":"Breast Cancer (Yau 2010)","url":"http://www.ncbi.nlm.nih.gov/pubmed/20946665","dataSubType":"phenotype","label":"Phenotypes","author":"Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC.","articletitle":"A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.","tags":["cancer"],"name":"YauClinical_public/YauClinical_public_clinicalMatrix","sample_type":["tumor"],"clinicalfeature":"YauClinical_public/YauClinical_public_clinicalFeature","type":"clinicalMatrix","wrangler":"Mia Grifford","version":"2011-11-11","primary_disease":"breast cancer","pmid":"20946665","description":"Phenotype data, including survival data, in the study \"A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.\""}